Skip to main content
Year archive

BRAIN Biotech AG — 2026 filings

All 10 regulatory filings released by BRAIN Biotech AG (BNN) in 2026, sourced directly from the official regulator.

10 Filings
2026 Period
2026 filings (10)
Filing Released Lang
BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology
Regulatory Filings
2026-03-23 English
Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG
Declaration of Voting Results & Voting Rights Announcements
2026-03-11 English
BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds
Earnings Release Q1 2026
2026-02-25 English
Q1 statement / Q1 financial report 2025/2026
Interim / Quarterly Report Q1 2025
2026-02-25 English
FY 2024/25: BRAIN Biotech AG benefits from successful monetization of projects and strong corporate cost control
Report Publication Announcement
2026-01-14 English
Annual financial report 2024/2025
Annual Report FY 2024
2026-01-14 English
Report Publication Announcement 2026
Report Publication Announcement
2026-01-06 English
Hinweis auf Konzernabschluss vom 01.10.2024 bis zum 30.09.2025
Report Publication Announcement
2026-01-06 German
Hinweis auf Konzernabschluss vom 01.10.2024 bis zum 30.09.2025
Report Publication Announcement
2026-01-06 German
Hinweis auf Konzernabschluss vom 01.10.2024 bis zum 30.09.2025
Report Publication Announcement
2026-01-06 German